Ever since the ability of the p53 tumor suppressor protein to bind DNA in a sequence-specific manner was established [1],[2], the specificity of p53 genomic binding has been intensively studied to gain insight into the network of p53 dependent target genes and their role in ensuring genomic protection and tumor suppression [3]. This evidence concerns the gene TP53 and neoplasm.